Position in ESPR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$0
+$0 QoQ
Shares Held
14,157
-93.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Headlands Technologies LLC holds $12,343,549 across 11 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
8,228 | $4,458,177 | |
| 2 | ZTS |
Zoetis Inc.
|
55,106 | $3,959,917 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
18,161 | $1,161,395 | |
| 4 | ALKS |
Alkermes plc.
|
14,313 | $750,001 | |
| 5 | TLRY |
Tilray Brands, Inc.
|
160,665 | $721,385 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
45,351 | $453,510 | |
| 7 | CRON |
Cronos Group Inc.
|
127,364 | $354,071 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
6,535 | $303,942 |
All Filings in ESPR
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 14,157 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | — | 221,088 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | — | 96,258 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | — | 38,447 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | — | 255,066 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | — | 164,544 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | — | 276,260 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | — | 3,208 | Shares | Sole | 2024-02-02 | |
| 2023-06-30 | — | 2,110 | Shares | Sole | 2023-08-03 | |
| No filing history on record for this holder in this stock. | ||||||